Skip to main content
Arcadia Biosciences, Inc. logo

Arcadia Biosciences, Inc. — Investor Relations & Filings

Ticker · RKDA ISIN · US0390142042 LEI · 54930027ZPNA80B8O763 US Agriculture, forestry and fishing
Open in API
Filings indexed 564 across all filing types
Latest filing 2016-05-26 Director's Dealing
Country US United States of America
Listing US RKDA

About Arcadia Biosciences, Inc.

https://arcadiabio.com/

Arcadia Biosciences, Inc. is a company focused on developing and marketing plant-based health and wellness products. With a foundation in agricultural innovation, the company cultivates next-generation ingredients and consumer goods. Its primary focus is a portfolio of specialty wheat ingredients designed to offer enhanced nutritional benefits, such as increased fiber, improved protein quality, reduced allergenic gluten, and higher amino acid content. Arcadia aims to transform wheat into a functional food ingredient, collaborating with food manufacturers to create healthier formulations of consumer products. In addition to its wheat ingredients, the company's brand portfolio includes Zola, a line of natural coconut water products.

Recent filings

Filing Released Lang Actions
FORM 4 SUBMISSION
Director's Dealing
2016-05-26 English
FORM 3 SUBMISSION
Director's Dealing
2016-05-24 English
10-Q
Interim / Quarterly Report Q1 2016
2016-05-10 English
8-K
Board/Management Information Classification · 95% confidence The document is a Form 8-K current report filed with the SEC, dated May 10, 2016. It includes two main items: Item 2.02, which announces the issuance of a press release with first quarter 2016 financial results, and Item 5.02, which announces the appointment of a new President and CEO, including details of his compensation and severance agreement. The document is not the financial report itself but a current report announcing these events. The length is 9787 characters, which is substantial but the content is clearly an 8-K filing reporting operational results and management changes. The presence of Item 5.02 (Departure/Election of Directors or Officers) and the detailed announcement of the new CEO appointment aligns with Board/Management Information filings. The financial results announcement is referenced as a press release attached as an exhibit, not the report itself. Therefore, the primary classification is Board/Management Information (MANG).
2016-05-10 English
FORM 4 SUBMISSION
Director's Dealing
2016-04-28 English
DEFA14A
Proxy Solicitation & Information Statement Classification · 100% confidence The document is a Schedule 14A filing, which is a Proxy Statement filed pursuant to Section 14(a) of the Securities Exchange Act of 1934. It includes information about the Annual Meeting of stockholders, voting instructions, and details about director elections and auditor ratification. The document is titled 'Definitive Additional Materials' related to the proxy statement and does not contain financial statements or detailed financial analysis. It is primarily a solicitation of shareholder votes and proxy materials. Therefore, it fits the category of Proxy Solicitation & Information Statement (PSI).
2016-04-22 English

Browse filings by year

14 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.